Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Sell
1,009
-70
-6% -$29.4K ﹤0.01% 730
2026
Q1
$408K Sell
1,079
-51
-5% -$21.8K ﹤0.01% 788
2025
Q4
$483K Buy
1,130
+76
+7% +$33.1K ﹤0.01% 782
2025
Q3
$472K Buy
1,054
+216
+26% +$97.8K ﹤0.01% 790
2025
Q2
$408K Sell
838
-213
-20% -$121K ﹤0.01% 852
2025
Q1
$647K Sell
1,051
-49
-4% -$27.9K ﹤0.01% 655
2024
Q4
$583K Sell
1,100
-16
-1% -$9.02K ﹤0.01% 728
2024
Q3
$671K Sell
1,116
-23
-2% -$13K ﹤0.01% 710
2024
Q2
$618K Buy
1,139
+136
+14% +$77.9K ﹤0.01% 749
2024
Q1
$644K Sell
1,003
-60
-6% -$36.5K ﹤0.01% 790
2023
Q4
$622K Sell
1,063
-116
-10% -$64.9K ﹤0.01% 828
2023
Q3
$613K Sell
1,179
-1,414
-55% -$735K ﹤0.01% 753
2023
Q2
$1.4M Sell
2,593
-157
-6% -$85.8K 0.01% 757
2023
Q1
$1.48M Buy
2,750
+788
+40% +$402K 0.01% 748
2022
Q4
$1M Sell
1,962
-1,433
-42% -$698K ﹤0.01% 823
2022
Q3
$1.48M Sell
3,395
-779
-19% -$375K 0.01% 809
2022
Q2
$1.96M Sell
4,174
-476
-10% -$232K 0.01% 835
2022
Q1
$2.35M Sell
4,650
-582
-11% -$279K 0.01% 763
2021
Q4
$2.77M Buy
5,232
+1,584
+43% +$761K 0.01% 719
2021
Q3
$1.7M Buy
+3,648
New +$1.72M 0.01% 798
2021
Q2
Sell
-2,581
Closed -$1.19M 887
2021
Q1
$1.19M Sell
2,581
-30
-1% -$14.7K 0.01% 865
2020
Q4
$1.39M Sell
2,611
-2,118
-45% -$1.04M 0.01% 797
2020
Q3
$2.27M Sell
4,729
-422
-8% -$207K 0.01% 708
2020
Q2
$2.32M Sell
5,151
-3,514
-41% -$1.57M 0.01% 659
2020
Q1
$3.75M Buy
8,665
+4,230
+95% +$1.89M 0.03% 508
2019
Q4
$1.95M Buy
+4,435
New +$1.87M 0.01% 742

Other funds holding CHE

Aviva's CHE Position: Q2 2026 in Review

Aviva reduced its Chemed (CHE) stake by 6.5% in Q2 2026, selling an estimated $29.4K and leaving 1,009 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Aviva first reported a position in CHE in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.75M in Q1 2020. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Aviva held 1,009 shares of Chemed worth $470K as of Q2 2026.
  • Aviva sold 70 Chemed shares in Q2 2026, an estimated $29.4K.
  • Chemed made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #730 holding.
  • Aviva first reported a position in Chemed in Q4 2019 and has held it in 26 quarters since.
  • Aviva's Chemed position peaked at $3.75M in Q1 2020.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.